mTORC2 regulates PGE2-mediated endothelial cell survival and migration

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Prostaglandin E(2) (PGE(2)) is known to promote angiogenesis, a process vital for blood vessel formation.
• Endothelial cell survival and migration are key events in angiogenesis.
• The mechanistic target of rapamycin (mTOR) pathway, with its complexes mTORC1 and mTORC2, plays a significant role in cellular processes.

Purpose of the Study:

• To investigate the specific roles of mTORC1 and mTORC2 in mediating the effects of PGE(2) on endothelial cells.
• To elucidate the molecular mechanisms by which PGE(2) influences endothelial cell responses via mTOR signaling.

Main Methods:

• Utilized small interfering RNA (siRNA) to selectively inhibit raptor (for mTORC1) and rictor (for mTORC2).
• Assessed endothelial cell survival and migration under baseline and PGE(2)-stimulated conditions after mTORC1 or mTORC2 knockdown.
• Examined the activation of downstream signaling molecules, Rac and Akt, using Western blotting or similar techniques.
• Confirmed findings using rapamycin to inhibit mTORC2 activity.

Main Results:

• Down-regulation of mTORC2, but not mTORC1, significantly reduced both baseline and PGE(2)-induced endothelial cell survival and migration.
• Knockdown of mTORC2 abolished PGE(2)-mediated activation of Rac and Akt.
• Pharmacological inhibition of mTORC2 with rapamycin corroborated the siRNA findings, impairing PGE(2)-driven endothelial cell responses.

Conclusions:

• mTORC2 is a critical signaling component in PGE(2)-mediated endothelial cell survival and migration.
• mTORC1 is not significantly involved in these specific PGE(2)-induced endothelial cell functions.
• Targeting mTORC2 may offer a strategy to modulate angiogenesis-related processes.